Literature DB >> 21160971

Partial blockage of hepatocyte maturation in hepatoma-derived growth factor transgenic mice.

Hirayuki Enomoto1, Hideji Nakamura, Naoko Komatsu-Kanatani, Yu Liu, Kenya Yoshida, Yorihide Okuda, Teruhisa Yamamoto, Weidong Liu, Shuhei Nishiguchi.   

Abstract

AIM: To investigate the role of hepatoma-derived growth factor (HDGF) in liver development, especially in the hepatocyte differentiation.
METHODS: We generated transgenic mice which overexpressed HDGF in hepatocytes under the transcriptional control of mouse albumin promoter/enhancer. To examine the effects of HDGF overexpression on hepatocyte differentiation, we investigated the expression patterns of the differentiation marker genes.
RESULTS: The HDGF transgenic mice developed normally and showed no apparent abnormality in the liver. However, the gene expression patterns of the liver in adult transgenic mice were similar to those of the neonatal liver in control mice.
CONCLUSION: These findings suggest that HDGF-overexpression partially suppresses hepatocyte maturation.

Entities:  

Keywords:  Hepatocyte; Hepatoma-derived growth factor; Maturation; Transgenic mice

Year:  2009        PMID: 21160971      PMCID: PMC2999260          DOI: 10.4254/wjh.v1.i1.98

Source DB:  PubMed          Journal:  World J Hepatol


  32 in total

1.  Fetal liver development requires a paracrine action of oncostatin M through the gp130 signal transducer.

Authors:  A Kamiya; T Kinoshita; Y Ito; T Matsui; Y Morikawa; E Senba; K Nakashima; T Taga; K Yoshida; T Kishimoto; A Miyajima
Journal:  EMBO J       Date:  1999-04-15       Impact factor: 11.598

2.  Expression of hepatoma-derived growth factor is correlated with lymph node metastasis and prognosis of gastric carcinoma.

Authors:  Shinji Yamamoto; Yasuhiko Tomita; Yoshihiko Hoshida; Shuji Takiguchi; Yoshiyuki Fujiwara; Takushi Yasuda; Yuichiro Doki; Kenya Yoshida; Katsuyuki Aozasa; Hideji Nakamura; Morito Monden
Journal:  Clin Cancer Res       Date:  2006-01-01       Impact factor: 12.531

3.  Hepatoma-derived growth factor is a novel prognostic factor for hepatocellular carcinoma.

Authors:  Kenya Yoshida; Yasuhiko Tomita; Yorihide Okuda; Shinji Yamamoto; Hirayuki Enomoto; Hirokazu Uyama; Hiroaki Ito; Yoshihiko Hoshida; Katsuyuki Aozasa; Hiroaki Nagano; Masato Sakon; Ichiro Kawase; Morito Monden; Hideji Nakamura
Journal:  Ann Surg Oncol       Date:  2006-01-17       Impact factor: 5.344

4.  Hepatoma-derived growth factor stimulates cell growth after translocation to the nucleus by nuclear localization signals.

Authors:  Yoshihiko Kishima; Hiroyasu Yamamoto; Yoshitaka Izumoto; Kenya Yoshida; Hirayuki Enomoto; Mitsunari Yamamoto; Toshifumi Kuroda; Hiroaki Ito; Kazuyuki Yoshizaki; Hideji Nakamura
Journal:  J Biol Chem       Date:  2001-12-18       Impact factor: 5.157

5.  Changing patterns of transcriptional and post-transcriptional control of liver-specific gene expression during rat development.

Authors:  A Panduro; F Shalaby; D A Shafritz
Journal:  Genes Dev       Date:  1987-12       Impact factor: 11.361

6.  Hepatoma-derived growth factor stimulates smooth muscle cell growth and is expressed in vascular development.

Authors:  A D Everett; D R Lobe; M E Matsumura; H Nakamura; C A McNamara
Journal:  J Clin Invest       Date:  2000-03       Impact factor: 14.808

7.  Nuclear targeting is required for hepatoma-derived growth factor-stimulated mitogenesis in vascular smooth muscle cells.

Authors:  A D Everett; T Stoops; C A McNamara
Journal:  J Biol Chem       Date:  2001-07-31       Impact factor: 5.157

8.  Developmental control of gene expression of tryptophan 2,3-dioxygenase in neonatal rat liver.

Authors:  M Nagao; T Nakamura; A Ichihara
Journal:  Biochim Biophys Acta       Date:  1986-08-22

9.  Oncofetal antigens as tumor markers in the cytologic diagnosis of effusions.

Authors:  S R Orell; K D Dowling
Journal:  Acta Cytol       Date:  1983 Nov-Dec       Impact factor: 2.319

Review 10.  Clinical utility of oncofetal proteins and hormones as tumor markers.

Authors:  P E Garrett; S R Kurtz
Journal:  Med Clin North Am       Date:  1986-11       Impact factor: 5.456

View more
  1 in total

1.  Overexpression of hepatoma-derived growth factor in melanocytes does not lead to oncogenic transformation.

Authors:  Angela Sedlmaier; Nicolas Wernert; Rainer Gallitzendörfer; Mekky M Abouzied; Volkmar Gieselmann; Sebastian Franken
Journal:  BMC Cancer       Date:  2011-10-20       Impact factor: 4.430

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.